|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/60 | |
| C07K 1/107 | |||
| C07C 309/42 | |||
| A61K 47/54 | |||
| C07K 14/605 | |||
| C07K 14/62 |
| (11) | Number of the document | 3534962 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17800769.6 |
| Date of filing the European patent application | 2017-11-07 | |
| (97) | Date of publication of the European application | 2019-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/078457 |
| Date | 2017-11-07 |
| (87) | Number | WO 2018/083335 |
| Date | 2018-05-11 |
| (30) | Number | Date | Country code |
| 16197464 | 2016-11-07 | EP | |
| 17181621 | 2017-07-17 | EP |
| (72) |
BIRKEBĘK JENSEN, Kim, DK
BERNT FREDRIK GUSTAFSSON, Magnus, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | DCHBS-ACTIVE ESTERS OF PEG COMPOUNDS AND THEIR USE |
| DCHBS-ACTIVE ESTERS OF PEG COMPOUNDS AND THEIR USE |